Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid

Journal of Neural Transmission

Volumn 103, Issue 8-9, 1996, Pages 1069-1076

  Maruyama, W ^a,b   Narabayashi, H ^c   Dostert, P ^d   Naoi, M ^e  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c Neurological Clinic   (Japan)

^d PFIZER INC   (United States)

^e NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Catechol isoquinolinium ion; Dopamine; Intraventricular fluid; N methylsalsolinol; Neurotoxin; Parkinson's disease

Indexed keywords

ACETALDEHYDE; ANTIPARKINSON AGENT; DOPAMINE; ISOQUINOLINE; LEVODOPA; N METHYLSALSOLINOL; SALSOLINOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 0029824010     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01291791     Document Type: Article

References (20)

1. Bembenek ME, Abell CW, Chrisey LA, Rozwadoeska MD, Gesner W, Brossi A (1990) Inhibition of monoamine oxidase A and B by simple isoquinoline alkaloids; racemic and optically active 1,2,3,4-tetrahydro-3,4-dihydro, and fully aromatic isoquinolines. J Med Chem 33: 147-152
2. Blennow K, Wallin A, Gottfries CG, Mansson JE, Svennerholm L (1993) Concentration gradients for monoamine metabolites in lumbar cerebrospinal fluid. J Neural Transm [P-D Sect] 5: 5-15
3. Dostert P, Strolin Benedetti M, Dedieu M (1987) Ratio of enantiomers of salsolinol in human urine. Pharmacol Toxicol 60 [Suppl] 1:13
4. Dostert P, Strolin Benedetti M, Dordain G, Vernay D (1989) Enantiomeric composition of urinary salsolinol in Parkinsonian patients after Madopar. J Neural Transm [P-D Sect] 1: 61-74
5. Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study. J Neurochem 59: 395-400
6. Maruyama W, Dostert P, Matsubara K, Naoi M (1995) N-Methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Rad Biol Med 19: 67-75
7. Maruyama W, Abe T, Tohgi H, Dostert P, Naoi M (1996a) A dopaminergic neurotoxin. (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann Neurol (in press)
8. Maruyama W, Naoi M, Narabayashi H (1996b) The mechanism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients. J Neurol Sci (in press)
9. + analogues, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology 45: 2240-2245
10. Moser A, Scholz J, Nobbe F, Vieregge P, Böhme V, Bamberg H (1995) Presence of N-methyl-norsalsolinol in the CSF: correlation with dopamine metabolites of patients with Parkinson's disease. J Neurol Sci 131: 183-189
11. Naoi M, Maruyama W, Dostert P (1994) Binding of 1,2(N)-dimethyl-6,7-dihydroxy-isoquinolinium ion to melanin: effects of ferrous and ferric ion on the binding. Neurosci Lett 171: 9-12
12. Naoi M, Maruyama W, Dosterl P (1995a) Dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines; oxidation and neurotoxicity. In: Yu P, Tipton KF, Boulton AA (eds) Progress in brain research, vol 106. Eisevier, Amsterdam, pp 227-239
13. Naoi M, Maruyama W, Zhang JH, Takahashi T, Deng Y, Dostert P (1995b) Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 1(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci 57: 1061-1066
14. Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996a) Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res 709: 285-295
15. Naoi M, Maruyama W, Dostert P, Hashizume Y (1996b) Animal model of Parkinson's disease induced by naturally-occurring 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. Biogen Amines 12: 135-147
16. Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Yoshida M, Dostert P, Naoi M, Nagatsu T (1991) Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal brains. Biochem Biophys Res Commun 177: 603-609
17. Origitano T, Hannigan J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224: 446-451
18. Sällström Baum S, Rommelspacher H (1994) Determination of total dopamine, R- and S-salsolinol in human plasma by cyclodextrin bonded-phase liquid chromatography with electrochemical detection. J Chromatogr B 660: 235-241
19. Takahashi T, Deng Y, Maruyama W, Dostert P, Kawai M, Naoi M (1994) Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm [GenSect] 98: 107-118
20. Teitel S, O'Brien J, Brossi A (1972) Alkaloids in mammalian tissue II. Synthesis of (+) and (-)substituted-6,7-dihvdroxy-l,2,3.4-tetrahydroisoquinolines. J Med Chem 15: 845-846